GWAM
ABBV icon

Guardian Wealth Advisors (Minnesota)’s AbbVie ABBV Stock Holding History

Guardian Wealth Advisors (Minnesota)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
4,781
-349
-7% -$77.4K 0.6% 17
2025
Q4 		$1.17M Sell
5,130
-650
-11% -$148K 0.66% 16
2025
Q3 		$1.34M Sell
5,780
-191
-3% -$38.9K 0.76% 16
2025
Q2 		$1.11M Sell
5,971
-181
-3% -$33.6K 0.66% 19
2025
Q1 		$1.29M Sell
6,152
-366
-6% -$71.2K 0.83% 18
2024
Q4 		$1.16M Sell
6,518
-169
-3% -$31.1K 0.74% 18
2024
Q3 		$1.32M Buy
6,687
+40
+0.6% +$7.46K 0.82% 18
2024
Q2 		$1.14M Sell
6,647
-157
-2% -$26K 0.74% 17
2024
Q1 		$1.24M Sell
6,804
-194
-3% -$33.4K 0.81% 15
2023
Q4 		$1.08M Buy
6,998
+40
+0.6% +$5.83K 0.76% 15
2023
Q3 		$1.04M Buy
6,958
+4
+0.1% +$587 0.79% 16
2023
Q2 		$937K Sell
6,954
-2
-0% -$293 0.69% 18
2023
Q1 		$1.11M Buy
6,956
+347
+5% +$53.1K 0.87% 15
2022
Q4 		$1.07M Sell
6,609
-2
-0% -$307 0.95% 15
2022
Q3 		$887K Buy
6,611
+55
+0.8% +$7.89K 0.86% 18
2022
Q2 		$1M Buy
6,556
+27
+0.4% +$4.13K 0.92% 18
2022
Q1 		$1.06M Sell
6,529
-165
-2% -$24K 0.87% 19
2021
Q4 		$906K Buy
6,694
+148
+2% +$17.5K 0.73% 21
2021
Q3 		$706K Sell
6,546
-618
-9% -$70.6K 0.63% 23
2021
Q2 		$807K Sell
7,164
-117
-2% -$13.2K 0.7% 22
2021
Q1 		$788K Buy
7,281
+24
+0.3% +$2.57K 0.73% 22
2020
Q4 		$778K Buy
+7,257
New +$697K 0.77% 24

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Guardian Wealth Advisors (Minnesota)'s ABBV Position: Q1 2026 in Review

Guardian Wealth Advisors (Minnesota) reduced its AbbVie (ABBV) stake by 6.8% in Q1 2026, selling an estimated $77.4K and leaving 4,781 shares worth $1.04M. The position accounts for 0.6% of the portfolio, ranked #17.

Guardian Wealth Advisors (Minnesota) first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.34M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Guardian Wealth Advisors (Minnesota) held 4,781 shares of AbbVie worth $1.04M as of Q1 2026.
  • Guardian Wealth Advisors (Minnesota) sold 349 AbbVie shares in Q1 2026, an estimated $77.4K.
  • AbbVie made up 0.6% of Guardian Wealth Advisors (Minnesota)'s portfolio in Q1 2026, its #17 holding.
  • Guardian Wealth Advisors (Minnesota) first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Guardian Wealth Advisors (Minnesota)'s AbbVie position peaked at $1.34M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Guardian Wealth Advisors (Minnesota)'s 13F filing for Q1 2026, filed 1 May 2026.